TransComplementation of an E1A-Deleted Adenovirus with Codelivered E1A Sequences to Make Recombinant Adenoviral Producer Cells
- 1 November 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 5 (11) , 1341-1348
- https://doi.org/10.1089/hum.1994.5.11-1341
Abstract
Replication-incompetent adenovirus is conventionally produced by cells that supply replication-enabling proteins from viral sequences present in trans. As an alternative means of recombinant adenovirus production, replication-enabling E1A sequences were cotransduced into human prostate carcinoma cells infected with an E1A-deleted adenovirus containing a luciferase expression cassette. The replication-enabling plasmid was cotransduced by ionic linkage to the recombinant adenovirus exterior. Cells cotransduced with the replication-enabling plasmid made new adenovirus with titers up to 8 × 106 in the supernatants 72–120 hr after transduction. Like the parent virus, the virus present in the cotransduced supernatants and lysates was capable of transferring luciferase activity to new cells. The virus present in the cotransduced cell supernatants was amplified and shown to be identical to the parent virus by genomic analysis. It was concluded that simultaneous addition of a replication-defective adenovirus and a replication-enabling gene sequence in a trans configuration converts some of the cotransduced cells into recombinant adenovirus-producing cells. The authors have shown that cells infected with a replication-defective recombinant adenovirus can be converted into recombinant adenovirus producing cells by cotransduction of a replication-enabling plasmid. This concept was demonstrated by linking a plasmid containing E1A sequences to an E1A-deleted adenovirus containing a luciferase expression cassette. The trans complementation of a replication-defective adenovirus may provide a means of amplifying gene transduction in vivo, and may be applicable to other recombinant viruses that are conventionally produced with the assistance of packaging cell lines containing complementing viral functions.Keywords
This publication has 15 references indexed in Scilit:
- In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumorsJournal of Neurosurgery, 1994
- Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proceedings of the National Academy of Sciences, 1993
- An experimental model of retrovirus gene therapy for malignant brain tumorsJournal of Neurosurgery, 1993
- Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice.Proceedings of the National Academy of Sciences, 1993
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- A cell line that supports the growth of a defective early region 4 deletion mutant of human adenovirus type 2.Proceedings of the National Academy of Sciences, 1983
- Cis-acting induction of adenovirus transcriptionCell, 1983
- Mechanism of activation of early viral transcription by the adenovirus E1A gene productCell, 1981
- Functional Analysis of Adenovirus-5 Host-range Deletion Mutants Defective for Transformation of Rat Embryo CellsPublished by Cold Spring Harbor Laboratory ,1980
- Adenovirus 5 DNA sequences present and RNA sequences transcribed in transformed human embryo kidney cells (HEK-Ad-5 or 293)Virology, 1979